Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Radiology|August 1, 2023
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast CancersToulsie Ramtohul, Lounes Djerroudi, Emilie Lissavalid, et al.
Annales De Pathologie|February 17, 2026
[Invasive lobular carcinoma: Clinicopathologic and biological insights]Lounes Djerroudi, Rigleta Brahimaj, Ahmad El Sabeh-Ayoun, et al.
AIDS (London, England)|October 17, 2018
Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphomaHéloïse M Delagreverie, Laurence Gerard, Antoine Chaillon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2020
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinomaJean-Christophe Tille, André F Vieira, Caroline Saint-Martin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2024
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancerRomain-David Seban, Laurence Champion, Alexandre De Moura, et al.
Annals of Surgical Oncology|June 23, 2026
Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast CancerEmilie Laude, Celian Guyon, Louna Mossino Diaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2025
Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma-An Exploratory Analysis of the STIC CTC TrialJose Luis Sandoval, Nicolas Kiavue, Lounes Djerroudi, et al.
The Journal of Investigative Dermatology|July 27, 2018
Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous MelanomaJan Philipp Ramspott, Fériel Bekkat, Lloyd Bod, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumabRomain-David Seban, Emilie Arnaud, Delphine Loirat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 2024
Molecular and Clinical Portrait of HER2-low Invasive Lobular CarcinomasLounes Djerroudi, Ahmad El Sabeh-Ayoun, Camille Benoist, et al.
Pageof 4